“Dec A1c and major points about DM drugs. Metformin, sulfonylurea, pioglitazone, DDP-IV inhibitors, GPL1 receptor agonists”,”Metformin: 1-2%. initial agent, low risk hypoglycemia, risk lactic acidosis Sulfonylurea: 1-2%. met failure. weight gain/ hypoglycemia pioglitazone: 1-1.5%. 3rd line. fat, edema, CHF, bone fx, bladder ca. safe in renal issues. DDP: .5-.8. low risk hypoglycemia

“Dec A1c and major points about DM drugs. Metformin, sulfonylurea, pioglitazone, DDP-IV inhibitors, GPL1 receptor agonists”,”Metformin: 1-2%. initial agent, low risk hypoglycemia, risk lactic acidosis Sulfonylurea: 1-2%. met failure. weight gain/ hypoglycemia pioglitazone: 1-1.5%. 3rd line. fat, edema, CHF, bone fx, bladder ca. safe in renal issues. DDP: .5-.8. low risk hypoglycemia

safe w. renal failure GLP1: .5-1. weight loss.”